Collectively, these results indicate that sodium butyrate supplementation attenuated hepatic steatosis, improved lipid and glucose metabolism, and increased energy expenditure in mice fed an HFFD diet; however, GPR41 and GPR43 receptor knockout blocks the sodium butyrate attenuation of hepatic steatosis. The gene discussed is FFAR3; the disease is fatty liver disease.